Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

Advanced MRI Measures of Repair in Alemtuzumab Treated Patients

NCT01307332 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis

NCT01199640 ·Status: COMPLETED ·Phase: PHASE2

A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS

NCT07222956 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Magnetic Resonance Imaging Study of JM-4 in Multiple Sclerosis/Clinically Patients

NCT03887065 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

NCT00835770 ·Status: COMPLETED ·Phase: PHASE3

Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis

NCT02403570 ·Status: COMPLETED

A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

NCT00035529 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis

NCT02308670 ·Status: COMPLETED

Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409

NCT02255656 ·Status: COMPLETED ·Phase: PHASE4

Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses

NCT03021317 ·Status: TERMINATED ·Phase: PHASE4

Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis

NCT01932593 ·Status: COMPLETED ·Phase: NA

Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)

NCT01405820 ·Status: COMPLETED ·Phase: PHASE2

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

NCT05359653 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Advanced MRI Sequences in Multiple Sclerosis and Its Mimics

NCT03608605 ·Status: UNKNOWN

Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS

NCT00813969 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)

NCT00239655 ·Status: TERMINATED ·Phase: PHASE2

An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT01838668 ·Status: COMPLETED ·Phase: PHASE3

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

NCT06065670 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist

NCT01836055 ·Status: TERMINATED

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

NCT00930553 ·Status: COMPLETED ·Phase: PHASE3

Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis

NCT06592703 ·Status: RECRUITING ·Phase: PHASE1

A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years

NCT01847287 ·Status: COMPLETED

Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation

NCT04674280 ·Status: UNKNOWN

Mesenchymal Stem Cells for Multiple Sclerosis

NCT01730547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Disease Activity With Long Term Natalizumab Treatment

NCT02677077 ·Status: COMPLETED